These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35491266)

  • 21. Transforming nanomedicine manufacturing toward Quality by Design and microfluidics.
    Colombo S; Beck-Broichsitter M; Bøtker JP; Malmsten M; Rantanen J; Bohr A
    Adv Drug Deliv Rev; 2018 Mar; 128():115-131. PubMed ID: 29626549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quality by design (QbD) approaches in current pharmaceutical set-up.
    Mishra V; Thakur S; Patil A; Shukla A
    Expert Opin Drug Deliv; 2018 Aug; 15(8):737-758. PubMed ID: 30044646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality by Design: Concept to Applications.
    Swain S; Parhi R; Jena BR; Babu SM
    Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmaceutical product development: A quality by design approach.
    Pramod K; Tahir MA; Charoo NA; Ansari SH; Ali J
    Int J Pharm Investig; 2016; 6(3):129-38. PubMed ID: 27606256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Information Processing: Rate-Based Investigation of Cell Physiological Changes along Design Space Development.
    Sagmeister P; Wechselberger P; Herwig C
    PDA J Pharm Sci Technol; 2012; 66(6):526-41. PubMed ID: 23183649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advancing Mass Spectrometry Technology in cGMP Environments.
    Ren D
    Trends Biotechnol; 2020 Oct; 38(10):1051-1053. PubMed ID: 32718778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determination of critical quality attributes for monoclonal antibodies using quality by design principles.
    Alt N; Zhang TY; Motchnik P; Taticek R; Quarmby V; Schlothauer T; Beck H; Emrich T; Harris RJ
    Biologicals; 2016 Sep; 44(5):291-305. PubMed ID: 27461239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of quality by design to the development of analytical separation methods.
    Orlandini S; Pinzauti S; Furlanetto S
    Anal Bioanal Chem; 2013 Jan; 405(2-3):443-50. PubMed ID: 22941176
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementation of QbD for the development of a vaccine candidate.
    Haas J; Franklin A; Houser M; Maraldo D; Mikola M; Ortiz R; Sullivan E; Otero JM
    Vaccine; 2014 May; 32(24):2927-30. PubMed ID: 24598725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT).
    de Matas M; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; Oostra W; Weimer M; Öhrngren P; Rantanen J
    Eur J Pharm Sci; 2016 Jul; 90():2-7. PubMed ID: 27112991
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality by Design (QbD)-Based Process Development for Purification of a Biotherapeutic.
    Rathore AS
    Trends Biotechnol; 2016 May; 34(5):358-370. PubMed ID: 26879188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishing a control system using QbD principles.
    Kepert JF; Cromwell M; Engler N; Finkler C; Gellermann G; Gennaro L; Harris R; Iverson R; Kelley B; Krummen L; McKnight N; Motchnik P; Schnaible V; Taticek R
    Biologicals; 2016 Sep; 44(5):319-31. PubMed ID: 27430904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Scientific, statistical, practical, and regulatory considerations in design space development.
    Debevec V; Srčič S; Horvat M
    Drug Dev Ind Pharm; 2018 Mar; 44(3):349-364. PubMed ID: 29200316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Application of quality by design in granulation process for ginkgo leaf tablet (Ⅱ)： identification of critical quality attributes].
    Xu B; Cui XL; Yang C; Wang X; Shi XY; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1043-1047. PubMed ID: 29027414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Quality by design approaches for pharmaceutical development and manufacturing of Chinese medicine].
    Xu B; Shi XY; Wu ZS; Zhang YL; Wang Y; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1015-1024. PubMed ID: 29027410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The development and validation of a quality by design based process analytical tool for the inline quantification of Ramipril during hot-melt extrusion.
    Dadou SM; Senta-Loys Z; Almajaan A; Li S; Jones DS; Healy AM; Tian Y; Andrews GP
    Int J Pharm; 2020 Jun; 584():119382. PubMed ID: 32360547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality by design in pharmaceutical manufacturing: A systematic review of current status, challenges and future perspectives.
    Grangeia HB; Silva C; Simões SP; Reis MS
    Eur J Pharm Biopharm; 2020 Feb; 147():19-37. PubMed ID: 31862299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
    Aksu B; De Beer T; Folestad S; Ketolainen J; Lindén H; Lopes JA; de Matas M; Oostra W; Rantanen J; Weimer M
    Eur J Pharm Sci; 2012 Sep; 47(2):402-5. PubMed ID: 22749874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
    Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
    J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality cell therapy manufacturing by design.
    Lipsitz YY; Timmins NE; Zandstra PW
    Nat Biotechnol; 2016 Apr; 34(4):393-400. PubMed ID: 27054995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.